Trial shows Oxford-developed COVID-19 vaccine offers only “minimal” protection against mild to moderate illness from South Africa variant. Source

JOIN NCOV.LINK NEWSLETTER

And get notified everytime we publish a new Important announcements. We will not email you often, unless there are important things that need to get in touch with you, such as added new tools or new domain names.

By subscribing, you agree with our privacy policy and our terms of service.